S599 (2023-24 session)
NY State bill
Requires certain manufacturers of prescription drugs to notify the superintendent of any proposed increase of the wholesale acquisition cost of such prescription drugs.
- Title
- Requires certain manufacturers of prescription drugs to notify the drug utilization review board of the proposed increase of the wholesale acquisition cost of such prescription drugs
- Type
- New York State Senate bill
- Session
- 2023-24 session
- Status
- Senate Floor Calendar
- Latest action date
- 2023-06-01
- Introduced
- 2023-01-05
- Active version
- S599A
- Same as
- A1707
- Substituted by
- A1707
- Law section
- Insurance Law
Sponsors
- Julia Salazar State Senator, District 18
Co-sponsors
- John C. Liu State Senator, District 16
- Joseph P. Addabbo Jr. State Senator, District 15
Heard in committee
Same as
- A1707 (2023-24 session) NY State bill
Substituted by
- A1707 (2023-24 session) NY State bill
Committee meetings
Committee meetings that took this bill up, from the Senate's published agendas. The Assembly does not publish its committee agendas in machine-readable form, so an Assembly committee's consideration of a bill is not on this list.
- Health, 2023-01-17 Referred to committee; referred to Rules
- Rules, 2023-01-17 Third reading